ESC 2022: REVIVED Fails to Show Benefits of Percutaneous Coronary Intervention Over Medical Therapy in Heart Failure With Left Ventricular Dysfunction
Event and mortality rates continue to be high in patients with ischemic cardiomyopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.